GRITSTONE BIO INC. - COMMON STOCK

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

27 9月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 9月 2023 16:30:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 8月 2023 16:30:00 条件 Nasdaq GlobeNewswire

Gritstone bio and Genevant Sciences Announce Option and License Agreement

15 8月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

09 8月 2023 16:05:01 条件 Nasdaq GlobeNewswire

Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project

07 8月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 6月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications

08 6月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio to Participate in Upcoming Investor Conferences

01 6月 2023 16:30:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 5月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates

11 5月 2023 16:05:02 条件 Nasdaq GlobeNewswire

Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023

03 5月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL)

17 4月 2023 07:01:00 条件 Nasdaq GlobeNewswire

Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting

17 4月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 4月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023

04 4月 2023 18:30:00 条件 Nasdaq GlobeNewswire

Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting

15 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

09 3月 2023 16:05:01 条件 Nasdaq GlobeNewswire

Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 9, 2023

02 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire